Medicare billing address
CMS Medicare provider billing file
2050 Kenny RdColumbus, OH 43221
CMS public data · NPI 1053572115
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Alan B Sanderson, M.D.
Specialty
Credential
M.D.
NPI
1053572115
Primary source state
OH
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Alan B Sanderson, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2050 Kenny RdCMS Doctors & Clinicians file
1303 N Main StIn the 2024 CMS provider billing file, this NPI had 352 Medicare beneficiaries and 639 total services. The average beneficiary age was 72, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$71,414.06
Total Medicare payment amount
$50,614.83
Medicare beneficiaries
352
Total services
639
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
65%
CMS beneficiary-panel share
Hyperlipidemia
58%
CMS beneficiary-panel share
Mood disorders
33%
CMS beneficiary-panel share
Depression
30%
CMS beneficiary-panel share
Diabetes
29%
CMS beneficiary-panel share
Ischemic heart disease
25%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 182 | $86.26 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 82 | $121.75 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 79 | $158.81 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 52 | $87.63 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 43 | $56.43 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 39 | $171.41 |
| Nerve conduction, 3-4 studies | 34 | $103.16 |
| Nerve conduction, 7-8 studies | 31 | $164.70 |
| Nerve conduction, 5-6 studies | 30 | $119.12 |
| New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | 20 | $209.62 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1053572115. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Levetiracetam | Levetiracetam | 160 | 285.3 | $3,963.52 |
| 2 | Carbidopa-Levodopa | Carbidopa/Levodopa | 150 | 324.3 | $7,473.76 |
| 3 | Baclofen | Baclofen | 113 | 185.5 | $3,197.32 |
| 4 | Topiramate | Topiramate | 72 | 126 | $1,695.52 |
| 5 | Duloxetine Hcl | Duloxetine Hcl | 71 | 147 | $1,521.49 |
| 6 | Gabapentin | Gabapentin | 69 | 123.7 | $1,482.39 |
| 7 | Lamotrigine | Lamotrigine | 68 | 106.7 | $2,598.90 |
| 8 | Propranolol Hcl | Propranolol Hcl | 47 | 103 | $1,073.91 |
| 9 | Oxcarbazepine | Oxcarbazepine | 46 | 92.7 | $2,813.64 |
| 10 | Aimovig Autoinjector | Erenumab-Aooe | 44 | 53.8 | $39,185.17 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Ohio State University College Of Medicine
Graduation year
2008
Group/practice field
Ihc Health Services Inc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.